StocksFin Logo
Zealand Pharma A/S country of incorporation
|
|
Dr. Emmanuel Dulac Ph.D., PharmD, MBA
|
237 employees
NASDAQ | Healthcare | Biotechnology
InnovAge Holding Corp. country of incorporation
|
|
2,000 employees
NASDAQ | Healthcare | Medical Care Facilities
Q122 reported Mar 31, 2022 Reporting Period
$15.08M -68.5% vs. Q121 Revenues Q122
80.69% 60.2% vs. Q121 Gross Profit Margin
-1000% ! -97.4% vs. Q121 Net Profit Margin
-320.75M ! 12.9% vs. Q121 Free Cash Flow Q122
$-5.16 ! 10.7% vs. Q121 EPS Q122
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q122
Q123
Q123 reported Nov 8, 2022 Reporting Period
$171.22M -1.1% vs. Q122 Revenues Q123
12.51% -48.8% vs. Q122 Gross Profit Margin
-7.64% ! -271.9% vs. Q122 Net Profit Margin
5.46M -73.4% vs. Q122 Free Cash Flow Q123
$-0.1 ! -266.7% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q122
Q123
Loading...
Loading...
Ratios
As of
Mar 31, 2022
Dec 31, 2022
Quick Ratio
3.68
1.76
Current Ratio
4.79
1.88
Cash Ratio
3.4
0.94
Price to Book
6.04
3.12
Price to Sales
100
5.81
Price to Earnings
-4.81
-24.85